Vendor, Jerusalem, ISR
Alomone Lab Ltd.
UEI CEB6YSJNSZZ8, CAGE 2372A
1 award and $41,184 obligated between April 23, 2024 and April 23, 2024, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | $41,184 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40124P00077Purchase Order, April 23, 2024, Not Competed Under SAP, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The U. S. Food & Drug Administration, (Fda) Office of Acquisition and Grants Services (Oags) Seeks to Procure a Cder-2024-121580 SS PurchaseNAICS 325413, PSC 6505 | $41,184 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards